Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Validation of a photophobia symptom impact scale.

Cortez MM, Digre K, Uddin D, Hung M, Blitzer A, Bounsanga J, Voss MW, Katz BJ.

Cephalalgia. 2019 May 22:333102419845641. doi: 10.1177/0333102419845641. [Epub ahead of print]

PMID:
31116567
2.

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A.

Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27.

3.

Phenomenological Classification of Laryngeal Hyperadduction Revisited.

Tang CG, Mor N, Blitzer A.

Ear Nose Throat J. 2019 Aug;98(7):400-402. doi: 10.1177/0145561319837447. Epub 2019 Mar 26. No abstract available.

PMID:
30913916
4.

Interesting case of late Gore-Tex extrusion following medialization laryngoplasty.

Kirke DN, Blitzer A.

Laryngoscope. 2019 Jun;129(6):1420-1422. doi: 10.1002/lary.27514. Epub 2018 Nov 8.

PMID:
30408188
5.

A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity.

Simonyan K, Frucht SJ, Blitzer A, Sichani AH, Rumbach AF.

Sci Rep. 2018 Oct 31;8(1):16111. doi: 10.1038/s41598-018-34553-x.

6.

Unearthing a consistent bilateral R1 component of the laryngeal adductor reflex in awake humans.

Téllez MJ, Ulkatan S, Blitzer A, Sinclair CF.

Laryngoscope. 2018 Nov;128(11):2581-2587. doi: 10.1002/lary.27249. Epub 2018 Sep 8.

PMID:
30194734
7.

Dacryocystorhinostomy with a thulium:YAG laser-a case series.

Tang C, Rickert S, Mor N, Blitzer A, Leib M.

Ear Nose Throat J. 2018 Aug;97(8):E39-E42.

PMID:
30138525
8.

Adductor focal laryngeal Dystonia: correlation between clinicians' ratings and subjects' perception of Dysphonia.

Stewart CF, Sinclair CF, Kling IF, Diamond BE, Blitzer A.

J Clin Mov Disord. 2017 Dec 13;4:20. doi: 10.1186/s40734-017-0066-y. eCollection 2017.

9.

Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.

Blitzer A, Brin MF, Simonyan K, Ozelius LJ, Frucht SJ.

Laryngoscope. 2018 Jan;128 Suppl 1:S1-S9. doi: 10.1002/lary.27003. Epub 2017 Dec 8. Review.

10.

Steering Sheath for 2-Nostril Transnasal Office Laryngoscopy.

Hoffman HT, Stegall H, Wingler T, Blitzer A.

Ann Otol Rhinol Laryngol. 2018 Feb;127(2):99-104. doi: 10.1177/0003489417745091. Epub 2017 Dec 4.

PMID:
29199444
11.

Chemodenervation of the Larynx.

Kaye R, Blitzer A.

Toxins (Basel). 2017 Nov 2;9(11). pii: E356. doi: 10.3390/toxins9110356. Review.

12.

The saline challenge-A test of injection laryngoplasty outcome.

Kaye R, Sinclair C, Blitzer A.

Laryngoscope. 2018 May;128(5):1182-1185. doi: 10.1002/lary.26933. Epub 2017 Oct 9. No abstract available.

PMID:
28990675
13.

Central voice production and pathophysiology of spasmodic dysphonia.

Mor N, Simonyan K, Blitzer A.

Laryngoscope. 2018 Jan;128(1):177-183. doi: 10.1002/lary.26655. Epub 2017 May 23. Review.

14.

IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder.

Patel AA, Lerner MZ, Blitzer A.

Ann Otol Rhinol Laryngol. 2017 Apr;126(4):328-333. doi: 10.1177/0003489417693013. Epub 2017 Feb 1.

PMID:
28290229
15.

Phenotype- and genotype-specific structural alterations in spasmodic dysphonia.

Bianchi S, Battistella G, Huddleston H, Scharf R, Fleysher L, Rumbach AF, Frucht SJ, Blitzer A, Ozelius LJ, Simonyan K.

Mov Disord. 2017 Apr;32(4):560-568. doi: 10.1002/mds.26920. Epub 2017 Feb 10.

16.

Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients.

Lerner MZ, Mor N, Paek H, Blitzer A, Strome M.

Ann Otol Rhinol Laryngol. 2017 Apr;126(4):340-343. doi: 10.1177/0003489416688478. Epub 2017 Jan 19.

PMID:
28103701
17.

Directed balloon cytology of the esophagus: A novel device for obtaining circumferential cytologic sampling.

Patel AA, Strome M, Blitzer A.

Laryngoscope. 2017 May;127(5):1032-1035. doi: 10.1002/lary.26472. Epub 2017 Jan 16.

PMID:
28092117
18.

An open-label study of sodium oxybate in Spasmodic dysphonia.

Rumbach AF, Blitzer A, Frucht SJ, Simonyan K.

Laryngoscope. 2017 Jun;127(6):1402-1407. doi: 10.1002/lary.26381. Epub 2016 Nov 3.

19.

Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia.

Lerner MZ, Lerner BA, Patel AA, Blitzer A.

Laryngoscope. 2017 May;127(5):1131-1134. doi: 10.1002/lary.26265. Epub 2016 Sep 16.

PMID:
27633917
20.

Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia.

Mor N, Tang C, Blitzer A.

Otolaryngol Head Neck Surg. 2016 Sep;155(3):458-61. doi: 10.1177/0194599816644708. Epub 2016 May 3.

PMID:
27143711
21.

GNAL mutation in isolated laryngeal dystonia.

Putzel GG, Fuchs T, Battistella G, Rubien-Thomas E, Frucht SJ, Blitzer A, Ozelius LJ, Simonyan K.

Mov Disord. 2016 May;31(5):750-5. doi: 10.1002/mds.26502. Epub 2016 Feb 1.

22.

In Reference to "Partial Epiglottoplasty for Pharyngeal Dysphagia due to Cervical Spine Pathology".

Patel A, Tang CG, Blitzer A.

Otolaryngol Head Neck Surg. 2016 Apr;154(4):773. doi: 10.1177/0194599816631500. No abstract available.

PMID:
27045111
23.

Rho GTPase signaling promotes constitutive expression and release of TGF-β2 by human trabecular meshwork cells.

Pervan CL, Lautz JD, Blitzer AL, Langert KA, Stubbs EB Jr.

Exp Eye Res. 2016 May;146:95-102. doi: 10.1016/j.exer.2015.12.010. Epub 2015 Dec 30.

24.

Neural correlates of abnormal sensory discrimination in laryngeal dystonia.

Termsarasab P, Ramdhani RA, Battistella G, Rubien-Thomas E, Choy M, Farwell IM, Velickovic M, Blitzer A, Frucht SJ, Reilly RB, Hutchinson M, Ozelius LJ, Simonyan K.

Neuroimage Clin. 2015 Oct 30;10:18-26. doi: 10.1016/j.nicl.2015.10.016. eCollection 2016.

25.

The Effectiveness of Using Laryngeal Electromyography Guidelines for Injection Augmentation.

Tang CG, Mor N, Blitzer A.

JAMA Otolaryngol Head Neck Surg. 2015 Nov;141(11):1030. doi: 10.1001/jamaoto.2015.2413. No abstract available.

PMID:
26583511
26.

Onabotulinum toxin A dosage trends over time for adductor spasmodic dysphonia: A 15-year experience.

Tang CG, Novakovic D, Mor N, Blitzer A.

Laryngoscope. 2016 Mar;126(3):678-81. doi: 10.1002/lary.25551. Epub 2015 Aug 26.

PMID:
26308153
27.

Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection.

Mor N, Tang C, Blitzer A.

Toxins (Basel). 2015 Jul 24;7(8):2791-800. doi: 10.3390/toxins7082791. Review.

28.

Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.

Blitzer A, Brin MF, Stewart CF.

Laryngoscope. 2015 Aug;125(8):1751-7. doi: 10.1002/lary.25273. No abstract available.

PMID:
26200329
29.

In response to Palatal myoclonus: Algorithm for management with botulinum toxin based on clinical disease characteristics.

Sinclair CF, Blitzer A.

Laryngoscope. 2015 Oct;125(10):E355. doi: 10.1002/lary.25303. Epub 2015 Jul 7. No abstract available.

PMID:
26152860
30.

Functional Anatomy and Oncologic Barriers of the Larynx.

Mor N, Blitzer A.

Otolaryngol Clin North Am. 2015 Aug;48(4):533-45. doi: 10.1016/j.otc.2015.04.002. Epub 2015 Jun 22. Review.

PMID:
26111895
31.

Negative dystonia of the palate: a novel entity and diagnostic consideration in hypernasal speech.

Sinclair CF, Simonyan K, Brin MF, Blitzer A.

Laryngoscope. 2015 Jun;125(6):1426-32. doi: 10.1002/lary.25165. Epub 2015 Feb 3.

32.

Multilevel airway stenosis in patients with granulomatosis with polyangiitis (Wegener's).

Guardiani E, Moghaddas HS, Lesser J, Resta-Flarer F, Blitzer A, Bhora F, Lebovics R.

Am J Otolaryngol. 2015 May-Jun;36(3):361-3. doi: 10.1016/j.amjoto.2014.12.010. Epub 2014 Dec 31.

PMID:
25630847
33.

A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia.

Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzińska M, Momčilović D, Jinnah HA, Frei K, Pfeiffer RF, LeDoux MS.

Mol Genet Genomic Med. 2014 May;2(3):261-72. doi: 10.1002/mgg3.67. Epub 2014 Feb 11.

34.

The effect of different angiolytic lasers on resolution of subepithelial mucosal hematoma in an animal model.

Novakovic D, D'Elia J, Branski RC, Blitzer A.

Ann Otol Rhinol Laryngol. 2014 Jun;123(6):387-94.

PMID:
24671546
35.

Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics.

Sinclair CF, Gurey LE, Blitzer A.

Laryngoscope. 2014 May;124(5):1164-9. doi: 10.1002/lary.23485. Epub 2014 Mar 25.

PMID:
24668771
36.

Pathogenic variants in TUBB4A are not found in primary dystonia.

Vemula SR, Xiao J, Bastian RW, Momčilović D, Blitzer A, LeDoux MS.

Neurology. 2014 Apr 8;82(14):1227-30. doi: 10.1212/WNL.0000000000000294. Epub 2014 Mar 5.

37.

Commentary on the role of expert opinion in developing evidence-based guidelines.

Eibling D, Fried M, Blitzer A, Postma G.

Laryngoscope. 2014 Feb;124(2):355-7. doi: 10.1002/lary.24175. Epub 2013 Oct 22.

PMID:
24151042
38.

Oromandibular dystonia: long-term management with botulinum toxin.

Sinclair CF, Gurey LE, Blitzer A.

Laryngoscope. 2013 Dec;123(12):3078-83. doi: 10.1002/lary.23265. Epub 2013 Oct 5.

PMID:
24122897
39.

A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.

Guardiani E, Sadoughi B, Blitzer A, Sirois D.

Laryngoscope. 2014 Feb;124(2):413-7. doi: 10.1002/lary.24286. Epub 2013 Aug 5. Review.

PMID:
23818108
40.

Surgical management of airway dysfunction in Parkinson's disease compared with Parkinson-plus syndromes.

Sinclair CF, Gurey LE, Brin MF, Stewart C, Blitzer A.

Ann Otol Rhinol Laryngol. 2013 May;122(5):294-8.

PMID:
23815045
41.

Hoarseness evaluation: a transatlantic survey of laryngeal experts.

Sadoughi B, Fried MP, Sulica L, Blitzer A.

Laryngoscope. 2014 Jan;124(1):221-6. doi: 10.1002/lary.24178. Epub 2013 Jun 26.

PMID:
23804513
42.

Sonographic detection of basal ganglia abnormalities in spasmodic dysphonia.

Walter U, Blitzer A, Benecke R, Grossmann A, Dressler D.

Eur J Neurol. 2014 Feb;21(2):349-52. doi: 10.1111/ene.12151. Epub 2013 Apr 14.

PMID:
23581276
43.

A new paradigm for the management of essential vocal tremor with botulinum toxin.

Gurey LE, Sinclair CF, Blitzer A.

Laryngoscope. 2013 Oct;123(10):2497-501. doi: 10.1002/lary.24073. Epub 2013 Apr 1.

PMID:
23553653
44.

Tool use as situated cognition.

Blitzer A, Huebner B.

Behav Brain Sci. 2012 Aug;35(4):221-2. doi: 10.1017/S0140525X11002147. Epub 2012 Jun 15.

PMID:
22697895
45.

Commentary on "Bilateral cerebellar stroke presenting with acute dysphonia and late palatal tremor".

Simonyan K, Blitzer A.

Mov Disord. 2012 Mar;27(3):348. doi: 10.1002/mds.24915. No abstract available.

46.

Development and validation of a new clinically-meaningful rating scale for measuring lateral canthal line severity.

Kane MA, Blitzer A, Brandt FS, Glogau RG, Monheit GD, Narins RS, Paty JA, Waugh JM.

Aesthet Surg J. 2012 Mar;32(3):275-85. doi: 10.1177/1090820X12437784.

PMID:
22395318
47.

Topical Application of Green Tea Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) for Prevention of Recurrent Oral Neoplastic Lesions.

Yoon AJ, Shen J, Santella RM, Philipone EM, Wu HC, Eisig SB, Blitzer A, Close LG, Zegarelli DJ.

J Orofac Sci. 2012;4(10):43-50.

49.

Laryngeal manifestations of relapsing polychondritis and a novel treatment option.

Childs LF, Rickert S, Wengerman OC, Lebovics R, Blitzer A.

J Voice. 2012 Sep;26(5):587-9. doi: 10.1016/j.jvoice.2011.07.012. Epub 2011 Nov 13. Review.

PMID:
22082863
50.

Patient perceptions of factors leading to spasmodic dysphonia: a combined clinical experience of 350 patients.

Childs L, Rickert S, Murry T, Blitzer A, Sulica L.

Laryngoscope. 2011 Oct;121(10):2195-8. doi: 10.1002/lary.22168. Epub 2011 Sep 6.

PMID:
21898448

Supplemental Content

Loading ...
Support Center